PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
The Penn Center for Innovation’s 11th annual Celebration of Innovation is scheduled for Tuesday, December 1, 2026, where we will celebrate Penn faculty and other researchers named as inventors on patents issued to Penn this past fiscal year. During the celebratory program we will also present several special awards for exceptional achievements in technology innovation and commercial translation, including:
Deal of the Year
Emerging Inventor of the Year
Startup of the Year
The Paul D. Sehnert Partner of the Year
Inventor of the Year
Networking will begin at 4:30 pm and the program will start at approximately 5:15 pm. We hope you will be able to join us for the celebration, which will be held this year in the Amy Gutmann Hall Lobby & Auditorium (3317 Chestnut St, Philadelphia, PA 19104).
Innovation @ Penn: The Future of Precision Medicine
PCI is hosting our Innovation @ Penn program in San Francisco on January 11, 2027, at 3 pm. This event, held concurrently during the annual JP Morgan Healthcare Conference, is an excellent opportunity to learn about emerging areas of innovation and opportunities for partnership with Penn. The program attracts professionals from across the life science industry, the investor community, and other stakeholders, and provides a platform for in-depth discussions about emerging healthcare technologies and their practical applications.
PCI is honored to have an outstanding group of participants in this year’s panel, including Scott Claunch, RPH, President of TerraPower Isotopes: alongside three distinguished Penn Medicine faculty members: Robert Mach, PhD, The Britton Chance Professor of Radiology, Mark Sellmyer, MD, PhD, The Gerd Muehllehner Associate Professor of Radiology, and Neha Vapiwala, MD, FACR, FASTRO, FASCO, The Eli Glatstein Professor in Radiation Oncology. Kevin Mahoney, DBA, MBA, Chief Executive Officer, University of Pennsylvania Health System, will provide opening remarks.